What Is a Thoracoamniotic Shunt for Fetal Hydrops?
At a Glance
A thoracoamniotic shunt is a small tube placed in a baby's chest before birth to treat severe fluid buildup. It safely drains excess chest fluid into the amniotic sac, relieving dangerous pressure on the baby's heart and allowing their lungs to grow.
In this answer
4 sections
A thoracoamniotic shunt is a tiny, flexible tube that a fetal specialist places inside your baby’s chest while they are still in the womb. This tube acts as a continuous drain, removing dangerous fluid buildup (called a pleural effusion) from the baby’s chest cavity and emptying it out into the amniotic sac surrounding them [1][2]. By constantly draining this fluid, the shunt relieves pressure on the baby’s heart and allows their lungs the space they need to grow and develop [3][4].
Why is a Shunt Needed?
In cases of severe non-immune hydrops fetalis involving fluid in the chest, the excess fluid takes up critical space. The baby’s chest cavity is small, and if fluid fills it, the lungs cannot expand properly, leading to pulmonary hypoplasia (underdeveloped lungs) [1][5]. Furthermore, this intense pressure can squeeze the baby’s heart and major blood vessels, making it difficult for the heart to pump blood effectively [4][6]. This heart strain is often what triggers or worsens hydrops (widespread swelling) [6].
A thoracoamniotic shunt works by decompressing the chest space. Once the pressure is relieved, blood can flow more normally to the heart, which often helps the hydrops begin to reverse [3][6].
Important Considerations Before Surgery
Before proceeding with a shunt, your doctor will recommend a thorough evaluation. Because hydrops can be caused by many different underlying issues, checking for genetic or heart conditions ensures that a shunt is truly the best treatment path for your baby [7][8].
This evaluation usually includes a detailed fetal echocardiogram to check the baby’s heart structure, as well as genetic testing (like a chromosomal microarray or exome sequencing) [1][7]. Survival rates and the overall success of the shunt depend heavily on the underlying cause of the hydrops [7][8]. Additionally, the mother must be monitored for Maternal Mirror Syndrome, a rare but serious condition where her body starts to mimic the baby’s hydrops [9].
How is the Procedure Performed?
The placement of a thoracoamniotic shunt is a percutaneous (through the skin) procedure performed under continuous real-time ultrasound guidance [10][11]. While doctors refer to it as “minimally invasive” because it doesn’t require a large surgical incision, having a needle placed through your abdomen and into your baby’s chest is a significant and understandable source of anxiety.
- Anesthesia: You will typically be given local anesthesia to numb your belly. To ensure the baby’s safety, a separate medication is standardly administered directly to the baby (often via a small needle injection into their muscle) to prevent them from moving and feeling pain during the procedure [12].
- Placement: The doctor guides a thin needle and introducer sheath through your abdomen, through the wall of your uterus, and carefully into the pocket of fluid in the baby’s chest [12][13].
- Deploying the Shunt: A small tube, often called a “pigtail” or “double-coil” shunt (because its curled ends keep it from slipping out), is passed through the needle. One end stays inside the baby’s chest fluid, and the other end is left outside the baby’s body in the amniotic fluid [12][13].
- Drainage: The needle is removed, and the fluid immediately begins draining out of the baby’s chest and into the amniotic sac [1].
What Are the Risks and Recovery?
For babies with severe fluid buildup in the chest, placing a shunt can significantly improve their chances of survival. When the procedure successfully reverses hydrops and the underlying cause is treatable, survival rates can range between 72% and 81% [14][15][1]. Babies who make it to at least 32 weeks of pregnancy before delivery tend to have the best outcomes [14][15].
However, fetal intervention comes with risks that your care team will monitor closely:
- Maternal Recovery & Risks: After the procedure, you will likely be monitored in the hospital for a few hours or overnight before going home. You will be instructed to rest and watch for signs of labor. Like any procedure involving a needle, there are small risks of maternal infection, bleeding, or injury to surrounding organs [16][17].
- Pregnancy Risks: The procedure carries a risk of premature labor or water breaking early (preterm premature rupture of membranes, or PPROM) [16][17].
- Shunt Complications: The most common issue is that the shunt can move out of place, get kinked, or become blocked by the baby’s movements, which may require placing a new shunt [16][18].
- After Birth: At delivery, the medical team will immediately clamp or remove the shunt to prevent air from entering the baby’s chest (a complication called a pneumothorax) [19][14]. Even with a successful shunt, your baby will likely need immediate breathing support and specialized care in a Neonatal Intensive Care Unit (NICU) [1][19].
Common questions in this guide
What does a thoracoamniotic shunt do?
Will my baby feel pain during the shunt procedure?
What are the risks of placing a fetal chest shunt?
What happens to the thoracoamniotic shunt when my baby is born?
What is Maternal Mirror Syndrome?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the suspected underlying cause of my baby's fluid buildup, and how does that affect the overall success rate of the shunt?
- 2.How exactly will the baby receive medication to stay still and pain-free during the procedure?
- 3.What specific signs of preterm labor, water breaking, or infection should I be watching for immediately after I am discharged?
- 4.If the shunt moves out of place or gets blocked by the baby's movements before birth, what is our backup plan?
- 5.What will happen to the shunt the exact moment my baby is born, and what will their immediate NICU care look like?
- 6.How often will you monitor me for complications like Maternal Mirror Syndrome after the surgery?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (19)
- 1
[Perinatal outcomes of thoraco-amniotic shunting for severe primary fetal hydrothorax].
Wei X, Meng M, Zou G, et al.
Zhonghua fu chan ke za zhi 2018; (53(9)):590-594 doi:10.3760/cma.j.issn.0529-567x.2018.09.002.
PMID: 30293293 - 2
New intrauterine shunt for treatment of fetal fluid accumulation: single-center experience of first 17 cases.
Nørgaard LN, Søgaard K, Jensen LN, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019; (53(3)):418-420 doi:10.1002/uog.19074.
PMID: 29700877 - 3
Intrafetal fluid effusions and pulmonary growth after pleuroamniotic shunt in fetuses with severe hydrothorax.
Sánchez-Martínez F, Peláez-Jiménez A, Rojas-Pillaca R, et al.
Fetal diagnosis and therapy 2026; 1-12 doi:10.1159/000551305.
PMID: 41758746 - 4
Computational Study of Tesla Valve Design for Vesico-Amniotic Shunt to Manage Lower Urinary Tract Obstruction and Pleural Effusion.
Nakirekanti S, Sarkonda VC, Dong J, et al.
Bioengineering (Basel, Switzerland) 2025; (12(10)) doi:10.3390/bioengineering12101126.
PMID: 41155124 - 5
In utero congenital chylothorax treatment with fetal thoracoamniotic shunt: Case report.
Hannah DM, Badell ML, Woodham PC
Journal of neonatal-perinatal medicine 2020; (13(3)):427-430 doi:10.3233/NPM-190235.
PMID: 31744022 - 6
Cardiovascular Effects of a Thoracoamniotic Shunt in a Fetus Affected by Isolated Right Congenital Diaphragmatic Hernia and Hydrops.
Tartaglia S, Paciullo C, Visconti D, et al.
Cureus 2024; (16(2)):e54279 doi:10.7759/cureus.54279.
PMID: 38371432 - 7
The Value of Exome Sequencing in Thoracoamniotic Shunt for Severe Pleural Effusion with Fetal Hydrops: A Retrospective Clinical Study.
Wei X, Zhou X, Zhou J, et al.
Fetal diagnosis and therapy 2022; (49(3)):138-144 doi:10.1159/000521212.
PMID: 35139508 - 8
Cardiac Etiologies of Hydrops Fetalis.
Yuan SM
Zeitschrift fur Geburtshilfe und Neonatologie 2017; (221(2)):67-72 doi:10.1055/s-0042-123825.
PMID: 28561210 - 9
Etiology and perinatal outcomes between early and late-onset nonimmune hydrops fetalis.
Ergani SY, İbanoğlu MC, Çakır A, et al.
Revista da Associacao Medica Brasileira (1992) 2024; (70(7)):e20231723 doi:10.1590/1806-9282.20231723.
PMID: 39045931 - 10
Diagnosis and management of primary fetal pleural effusion: A narrative review.
Abiad M, Javinani A, Lopez MC, et al.
Best practice & research. Clinical obstetrics & gynaecology 2026; (105()):102707 doi:10.1016/j.bpobgyn.2026.102707.
PMID: 41621197 - 11
Primary fetal pleural effusion: Characteristics, outcomes, and the role of intervention.
Shamshirsaz AA, Erfani H, Aalipour S, et al.
Prenatal diagnosis 2019; (39(6)):484-488 doi:10.1002/pd.5462.
PMID: 31009092 - 12
Needle Fetal Thoracoscopy: A Technique to Assist with Ultrasound-Guided Placement of Challenging Thoracoamniotic Shunts.
Papastefan ST, Liesman DR, Ott KC, et al.
Fetal diagnosis and therapy 2025; (52(2)):178-184 doi:10.1159/000539274.
PMID: 38740011 - 13
Role of Imaging in Obstetric Interventions: Criteria, Considerations, and Complications.
Jha P, Feldstein VA, Revzin MV, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2021; (41(4)):1243-1264 doi:10.1148/rg.2021200163.
PMID: 34115536 - 14
Neonatal management and outcome after thoracoamniotic shunt placement for fetal hydrothorax.
Witlox RSGM, Klumper FJCM, Te Pas AB, et al.
Archives of disease in childhood. Fetal and neonatal edition 2018; (103(3)):F245-F249 doi:10.1136/archdischild-2016-311265.
PMID: 28780497 - 15
Long-Term Outcomes After Thoracoamniotic Shunt for Pleural Effusions With Secondary Hydrops.
Chon AH, Chmait HR, Korst LM, et al.
The Journal of surgical research 2019; (233()):304-309 doi:10.1016/j.jss.2018.08.022.
PMID: 30502263 - 16
Assessment of thoracoamniotic shunt catheter patency using pulsed-wave Doppler and color flow mapping: A case report.
Iwagaki S, Takahashi Y, Shimaoka R, et al.
The journal of obstetrics and gynaecology research 2025; (51(9)):e70040 doi:10.1111/jog.70040.
PMID: 40905392 - 17
Refractory tension pneumothorax as a result of an internally displaced thoracoamniotic shunt in an infant with a congenital pulmonary airway malformation.
Law BH, Bratu I, Jain V, Landry MA
BMJ case reports 2016; (2016()).
PMID: 27469386 - 18
Factors associated with fetal shunt dislodgement in lower urinary tract obstruction.
Kurtz MP, Koh CJ, Jamail GA, et al.
Prenatal diagnosis 2016; (36(8)):720-5 doi:10.1002/pd.4850.
PMID: 27247093 - 19
Postnatal Outcomes and Surgical Implications of Somatex™ Thoracoamniotic Shunting for CPAM: A Multicenter Experience.
Kohaut J, Oetzmann von Sochaczewski C, Heydweiller AC, et al.
European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie 2025; (35(6)):470-474 doi:10.1055/a-2631-4152.
PMID: 40550255
This page provides educational information about thoracoamniotic shunts and fetal hydrops. It does not replace professional medical advice from your maternal-fetal medicine specialist or care team.
Get notified when new evidence is published on Non-immune hydrops fetalis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.